GC WellBeing Corporation
KOSDAQ-listed company selling the placental hydrolysate injection Rainec Inj. and the HA filler Youthfill across pharmaceuticals and aesthetics.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2004 and listed on KOSDAQ in 2019, GC WellBeing is a company spanning prescription pharmaceuticals, health functional foods, and aesthetic medical devices. Its flagship product, Rainec Inj., Korea's only placental hydrolysate injection, is sold alongside 48 types of nutritional injections and medical devices such as the HA filler Youthfill, skin booster Pilode, and collagen booster Duragen, and the company has also begun domestic sales of the Swedish-strain botulinum toxin Inibo. 2025 standalone revenue was KRW 151.9 billion, up 18.8% from KRW 127.9 billion the prior year, and its physician-channel health functional food brand Dr.PNT offers around 32 products.
Products & technology
- Rainec Inj.Placental hydrolysate injection for liver function improvement
- Youthfill (HA filler)Class 4 medical device for facial volume and wrinkle correction
- IniboBotulinum toxin from a Swedish clean strain
- Dr.PNTPhysician-channel health functional food brand (vitamins, probiotics, etc.)
Regulatory approvals
data.go.kr45 Korean MFDS drug approvals · 1992–2025 / 1 Korean MFDS device approvals · 2025
- MFDS drugHealroad once Inj.2025-05-21Drug · Prescription · Approval202501248
- MFDSTraction unit, air-powered, manually-operatedRevoked2025-03-25Product approval · Class 1제신 25-363 호
- MFDS drugHealroad Plus Inj.2024-08-13Drug · Prescription · Approval202401971
- MFDS drugHealroad Inj.2023-10-30Drug · Prescription · Approval202303026
- MFDS drugGCWBVITATWO inj. (Riboflavin sodium phosphate)Revoked2022-06-15Drug · Prescription · Notification202202502
- MFDS drugGCWBVITANINE inj. (Folic Acid)2022-04-14Drug · Prescription · Notification202201561
- MFDS drugGCWB Magnesium Chloride inj.2021-02-19Drug · Prescription · Notification202101707
- MFDS drugGCWB Selenium Oral Dissolving Film2020-12-31Drug · OTC · Approval202009404
- MFDS drugGCWB BONHEALTH inj.2020-11-23Drug · Prescription · Notification202008109
- MFDS drugGC WellBeing Deoxy Inj.2020-11-09Drug · Prescription · Notification202007667
- MFDS drugGC Wellbeing Immun Alpha 1 Inj.2020-08-18Drug · Prescription · Approval202005847
- MFDS drugGC Wellbeing Acetaminophen Inj.2020-02-13Drug · Prescription · Notification202000931
Show 34 more
- MFDS drugGC WellBeing Neuramin Inj.Revoked2019-11-13Drug · Prescription · Notification201907901
- MFDS drugGC WellBeing Amino Inj.Revoked2019-11-13Drug · Prescription · Notification201907902
- MFDS drugPNT-sami Inj2019-07-30Drug · Prescription · Notification201905399
- MFDS drugGC vita12 Inj.2017-12-13Drug · Prescription · Notification201708334
- MFDS drugGCWB Glymeta Inj.2017-07-28Drug · Prescription · Notification201706238
- MFDS drugGC Ginkgo Injection2017-05-23Drug · Prescription · Notification201702532
- MFDS drugGC ARGININE inj.2016-12-19Drug · Prescription · Notification201607169
- MFDS drugGC SELENIUM inj.2016-10-28Drug · Prescription · Notification201606336
- MFDS drugGC Multi 5 Inj.2016-10-10Drug · Prescription · Notification201605985
- MFDS drugGC Multi 12 Inj.2016-09-01Drug · Prescription · Notification201605356
- MFDS drugGCB Bone Injection2016-02-11Drug · Prescription · Notification201600795
- MFDS drugGC CALCIUM GLUCONATE inj.2015-10-20Drug · Prescription · Notification201507258
- MFDS drugGC Tatihione Inj. 1200mg2015-08-31Drug · Prescription · Notification201506222
- MFDS drugGC VITAD inj.2015-06-30Drug · Prescription · Notification201504236
- MFDS drugEsozole Cap. 20mg(Esomeprazole pellets)2015-05-21Drug · Prescription · Approval201503039
- MFDS drugEsozole Cap. 40mg(Esomeprazole pellets)2015-05-21Drug · Prescription · Approval201503040
- MFDS drugGCNAC Inj.2015-02-24Drug · Prescription · Notification201500956
- MFDS drugGC Zinc Injection2015-01-20Drug · Prescription · Notification201500301
- MFDS drugGCTrace InjectionRevoked2015-01-19Drug · Prescription · Notification201500267
- MFDS drugGCtathione Injection 600mg2014-12-31Drug · Prescription · Notification201406164
- MFDS drugGC Vita O Injection2014-11-28Drug · Prescription · Notification201405626
- MFDS drugThioctic Acid Inj. GC2014-11-25Drug · Prescription · Notification201405517
- MFDS drugGC Cartine Inj.2014-10-27Drug · Prescription · Notification201404971
- MFDS drugLaennecP.O. Cap.Revoked2014-08-01Drug · OTC · Approval201403583
- MFDS drugLaennec P.O. CAPSULERevoked2014-03-13Drug · OTC · Approval201401144
- MFDS drugMeganessium Injection 10%2013-12-12Drug · Prescription · Notification201310661
- MFDS drugMegavitasix Injection2013-12-11Drug · Prescription · Notification201310621
- MFDS drugJ-Pla Injection2011-11-28Drug · Prescription · Approval201110423
- MFDS drugLainec Inj. Vial2011-02-23Drug · Prescription · Approval201100874
- MFDS drugHishiphagen-C Inj.2008-05-09Drug · Prescription · Notification200805354
- MFDS drugMegagreen2007-11-14Drug · Prescription · Notification200712460
- MFDS drugFursultamine Inj.2007-04-18Drug · Prescription · Notification200704485
- MFDS drugLaennec Inj.2005-04-13Drug · Prescription · Approval200512342
- MFDS drugPotemin Inj1992-06-09Drug · Prescription · Notification199200566
Clinical trials
data.go.kr4 MFDS clinical trial authorisations · 2017–2024 (Phase 3 2 · Phase 2a 2)
- Phase 3라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2024-04-25
37 trial sites
- Phase 2a라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2021-02-26
3 trial sites
- Phase 2a라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2020-08-11
8 trial sites
- Phase 3라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2017-11-14
3 trial sites
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot2
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition